AMYLASE POLYPEPTIDE
European patent · EP3346004 · In force
Register entry
- Publication number
- EP3346004
- Application number
- EP18153826
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 19, 2010
- Published
- Jul 11, 2018
- Granted
- Nov 13, 2019
- Protection ends at the latest
- May 18, 2030
- Next annual fee due
- May 31, 2026
- IPC classes
- C12N 9/28 (2006.01)C12P 19/14 (2006.01)
- Priority
- EP 09160655 19.05.2009US 179525 P 19.05.2009
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Jun 3, 2024
Address changed
- Owner
- DuPont Nutrition Biosciences ApS, Langebrogade 1, 1411 Copenhagen K, Denmark → International N&H Denmark ApS, Langebrogade 1, 1411 Copenhagen K, Denmark
Published in Swissreg on 03.06.2024
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 1, 2023
Change
Published in Swissreg on 01.06.2023
- Jan 9, 2023
Address changed
- Representative
- ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg
Published in Swissreg on 09.01.2023
- Jun 4, 2020
Address changed
- Representative
- Servopatent GmbH, Resirain 1, 8125 Zollikerberg → ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich
Published in Swissreg on 04.06.2020
- Jan 8, 2020
Agent entered
- Representative
- Servopatent GmbH, Resirain 1, 8125 Zollikerberg
Published in Swissreg on 08.01.2020
- Nov 13, 2019
Granted
Published in Swissreg on 13.11.2019
Parties
Inventor
Copenhagen V 1558, DK
8732 Hovedgaard, DK
8471 Sabro, DK
DK-8270 Hoejbjerg, DK
8752 Østbirk, DK
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.